Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy

OBJECTIVE: Diabetes mellitus is a chronic disease related to a significant impact in both epidemiologic and economic terms. In Italy, around 3.6 million people are affected by diabetes and this number is expected to increase significantly in the next few years. As recommended by current national and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzoni, Valentina, Baccetti, Fabio, Genovese, Stefano, Torre, Enrico, Turchetti, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700761/
https://www.ncbi.nlm.nih.gov/pubmed/29200879
http://dx.doi.org/10.2147/CEOR.S141477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700761/
https://www.ncbi.nlm.nih.gov/pubmed/29200879
http://dx.doi.org/10.2147/CEOR.S141477

Ejemplares similares